CPRD Feasibility Tool: MHRA wants a white-labelled analytics platform
- Medicines and Healthcare products Regulatory Agency (MHRA)
- Open procedure
- 24 December 2026 to 23 December 2029
The Medicines and Healthcare products Regulatory Agency (MHRA) wants a white-labelled feasibility and population analytics platform for CPRD data. It must run inside CPRD-managed Microsoft Azure and work natively with datasets in the OMOP Common Data Model.
CPRD staff and approved clients would use it without supplier help to count patients, test cohort feasibility and calculate incidence and prevalence. Standard queries must return results within 60 seconds. The supplier would earn a share of licence revenue, with no upfront payments and no separate support fees.
Quality counts for 90% of the score and social value for 10%, and the three highest-scoring bidders are then invited to present. The work is estimated at £3m. The deadline for bids is 19 November 2026, and extensions can take the contract to December 2031.
Closed 19 Nov 2026
- What
- Research data licences and secure data environments
- Estimated value
- £3m
- How it is being bought
- Open procedure
- Bids due
- 19 Nov 2026
- Contract dates
- Dec 2026 to Dec 2029
- Option to Dec 2031